Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free mice

Beneficial Microbes

Volumn 5, Issue 1, 2014, Pages 67-77

  El Aidy, S ^a,b   Derrien, M ^a,b,c   Aardema, R ^d,e   Hooiveld, G ^a   Richards, S E ^f   Dane, A ^d,e   Dekker, J ^a,b   Vreeken, R ^d,e   Levenez, F ^g   Dore J ^g   Zoetendal, E G ^a,b   van Baarlen, P ^a   Kleerebezem, M ^a,b,h  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^c DANONE RESEARCH   (France)

^d LEIDEN UNIVERSITY   (Netherlands)

^e NETHERLANDS METABOLOMICS CENTRE   (Netherlands)

^f NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^g UMR1319 MICALIS   (France)

^h NIZO FOOD RESEARCH   (Netherlands)

Author keywords

Conventionalisation; Microbiota; Plasma cytokines and metabolites; Transcriptome

Indexed keywords

CYTOKINE; TRANSCRIPTOME;

ARTICLE; DYSBIOSIS; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GERMFREE ANIMAL; HEALTH STATUS; HELICOBACTER; HOMEOSTASIS; IMMUNE SYSTEM; INTESTINE FLORA; MICROBIAL COLONIZATION; MICROFLORA; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; SPHINGOMONAS;

CONVENTIONALISATION; MICROBIOTA; PLASMA CYTOKINES AND METABOLITES; TRANSCRIPTOME;

AMINES; ANIMALS; CYTOKINES; DYSBIOSIS; GENE EXPRESSION PROFILING; GERM-FREE LIFE; HELICOBACTER; HOMEOSTASIS; INFLAMMATION; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICROBIOTA; SPHINGOMONAS;

EID: 84894377170     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0018     Document Type: Article

References (43)

1. Akobeng, A.K., Miller, V., Thomas, A.G. and Richmond, K., 2000. Glutamine supplementation and intestinal permeability in Crohn's disease. Journal of Parenteral and Enteral Nutrition 24: 196.
2. Bellows, C.F. and Jaffe, B.M., 1999. Glutamine is essential for nitric oxide synthesis by murine macrophages. Journal of Surgical Research 86: 213-219.
3. Berry, D., Schwab, C., Milinovich, G., Reichert, J., Ben Mahfoudh, K., Decker, T., Engel, M., Hai, B., Hainzl, E., Heider, S., Kenner, L., Müller, M., Rauch, I., Strobl, B., Wagner, M., Schleper, C., Urich, T. and Loy, A., 2012. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME Journal 6: 2091-2106.
4. Bogomoletz, W.V., Williams, G.T. and Potet, F., 1987. HID-blue alcian (High iron diamine-alcian blue) and the histochemistry of mucins in colonic pathology - 20 years later. Gastroenterology and Clinical Biology 11: 865-868.
5. Chinen, T., Kobayashi, T., Ogata, H., Takaesu, G., Takaki, H., Hashimoto, M., Yagita, H., Nawata, H. and Yoshimura, A., 2006. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFN gamma and IL-4 are involved. Gastroenterology 130: 373-388.
6. Chow, J. and Mazmanian, S.K., 2010. A pathobiont of the microbiota balances host colonisation and intestinal inflammation. Cell Host and Microbe 7: 265-276.
7. Chow, J., Tang, H. and Mazmanian, S.K., 2011. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Current Opinion in Immunology 23: 473-480.
8. Duan, R.D. and Nilsson, A., 2009. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Progress in Lipid Research 48: 62-72.
9. El Aidy, S., Derrien, M., Merrifield, C.A., Levenez, F., Doré, J., Boekschoten, M.V., Dekker, J., Holmes, E., Zoetendal, E.G., Van Baarlen, P., Claus, S.P. and Kleerebezem, M., 2012a. Gut bacteria-host metabolic interplay during conventionalisation of the mouse germfree colon. ISME Journal 7: 743-755.
10. El Aidy, S., Kunze, W., Bienenstock, J. and Kleerebezem, M., 2012d. The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine. Beneficial Microbes 3: 251-259.
11. El Aidy, S., Merrifield, C.A., Derrien, M., Van Baarlen, P., Hooiveld, G., Levenez, F., Doré, J., Dekker, J., Holmes, E., Claus, S.P, Reijngoud, D.J. and Kleerebezem, M., 2012b. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut 62: 1306-1314.
12. El Aidy, S., Van Baarlen, P., Derrien, Lindenbergh-Kortleve, D.J., Hooiveld, G., Levenez, F., Doré, J., Dekker, J., Samsom, J.N., Nieuwenhuis, E.E.S. and Kleerebezem, M., 2012c. Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunology 5: 567-579.
13. Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., Peaper, D.R., Bertin, J., Eisenbarth, S.C., Gordon, J.I. and Flavell, R.A., 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757.
14. Erdman, S.E., Rao, V.P., Poutahidis, T., Ihrig, M.M., Ge, Z., Feng, Y., Tomczak, M., Rogers, A.B., Horwitz, B.H. and Fox, J.G., 2003. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Research 63: 6042-6050.
15. Erdman, S.E., Rao, V.P., Poutahidis, T., Rogers, A.B., Taylor, C.L., Jackson, E.A., Ge, Z., Lee, C.W., Schauer, D.B., Wogan, G.N., Tannenbaum, S.R. and Fox. J.G., 2009. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proceedings of the National Academy of Sciences of the USA 106: 1027-1032.
16. Garrett, W.S., Gallini, C.A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M.L., Punit, S., Karlsson, M., Bry, L., Glickman, J.N., Gordon, J.I., Onderdonk, A.B. and Glimcher, L.H., 2010. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host and Microbe 8: 292-300.
17. Garrett, W.S., Punit, S., Gallini, C.A., Michaud, M., Zhang, D., Sigrist, K.S., Lord, G.M., Glickman, J.N. and Glimcher, L.H., 2009. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16: 208-219.
18. Hakansson, A. and Molin, G., 2011. Gut microbiota and inflammation. Nutrients 3: 637-682.
19. Heuschkel, R.B., MacDonald, T.T., Monteleone, G., Bajaj-Elliott, M., Smith, J.A. and Pender, S.L.F., 2000. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut 47: 57-62.
20. Kinjyo, I., Hanada, T., Inagaki-Ohara, K., Mori, H., Aki, D., Ohishi, M., Yoshida, H., Kubo, M. and Yoshimura, A., 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17: 583-591.
21. Lindén, S.K., Sutton, P., Karlsson, N.G., Korolik, V. and McGuckin, M.A., 2008. Mucins in the mucosal barrier to infection. Mucosal Immunology 1: 183-197.
22. Macpherson, A.J., Geuking, M.B. and McCoy, K.D., 2005. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 115: 153-162.
23. Mai, V., Young, C.M., Ukhanova, M., Wang, X., Sun, Y., Casella, G., Theriaque, D., Li, N., Sharma, R., Hudak, M. and Neu, J., 2011. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE 6: e20647.
24. Manco, M., Putignani, L. and Bottazzo, G.F., 2010. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocrine Reviews 31: 817-844.
25. Mattner, J., Debord, K.L., Ismail, N., Goff, R.D., Cantu III, C., Zhou, D., Saint-Mezard, P., Wang, V., Gao, Y., Yin, N., Hoebe, K., Schneewind, O., Walker, D., Beutler, B., Teyton, L., Savage, P.B. and Bendelac, A., 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
26. Morrow, A.L., Lagomarcino, A.J., Schibler, K.R., Taft, D.H., Yu, Z., Wang, B., Altaye, M., Wagner, M., Gevers, D., Ward, D.V., Kennedy, M.A., Huttenhower, C. and Newburg, D.S., 2013. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome 1: 13.
27. Nishimura, M., Kuboi, Y., Muramoto, K., Kawano, T. and Imai, T., 2009. Chemokines as novel therapeutic targets for inflammatory bowel disease. Annals of the New York Academy of Sciences 1173: 350-356.
28. O'Connor, S.M., Taylor, C.E. and Hughes, J.M., 2006. Emerging infectious determinants of chronic diseases. Emerging Infectious Diseases 12: 1051-1057.
29. Palmer, R., 2011. Fecal matters. Nature Medicine 17: 150-152.
30. Palmer, R.M., Ashton, D.S. and Moncada, S.,1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
31. Parker, N., Tsai, H.H., Ryder, S.D., Raouf, A.H. and Rhodes, J.M.,1995. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion 56: 52-56.
32. Rajilić-Stojanović, M., Heilig, H.G., Molenaar, D., Kajander, K., Surakka, A., Smidt, H. and De Vos, W.M., 2009. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environmental Microbiolology 11: 1736-1751.
33. Raouf, A.H., Tsai, H.H., Parker, N., Hoffman, J., Walker, R.J. and Rhodes, J.M., 1992. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clinical Science 83: 623-626.
34. Robertson, B.R., O'Rourke, J.L., Neilan, B.A., Vandamme, P., On, S.L., Fox, J.G. and Lee, A., 2005. Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. International Journal of Systematic and Evolutionary Microbiology 55: 1199-1204.
35. Singh, U.P., Venkataraman, C., Singh, R. and Lillard Jr., J.W., 2007. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocrine, Metabolic and Immune Disorders - Drug Targets 7: 111-123.
36. Spicer, S.S., 1965. Diamine methods for differentiating mucosubstances histochemically. Journal of Histochemistry and Cytochemistry 13: 211-234.
37. Stepankova, R., Powrie, F., Kofronova, O., Kozakova, H., Hudcovic, T., Hrncir, T., Uhlig, H., Read, S., Rehakova, Z., Benada, O., Heczko, P., Strus, M., Bland, P. and Tlaskalova-Hogenova, H., 2007. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RB(high) CD4+ T cells. Inflammatory Bowel Disease 13: 1202-1211.
38. Suzuki, Y., Suda, T., Furuhashi, K., Suzuki, M., Fujie, M., Hahimoto, D., Nakamura, Y., Inui, N., Nakamura, H. and Chida, K., 2010. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer. Lung Cancer 67: 361-365.
39. Walker, A., Sanderson, J., Churcher, C., Parkes, G., Hudspith, B., Rayment, N., Brostoff, J., Parkhill, J., Dougan, G. and Petrovska, L., 2011. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiology 11: 7.
40. Wang, D., Pezo, R.C., Corner, G., Sison, C., Lesser, M.L., Shenoy, S.M., Mariadason, J.M., Singer, R.H. and Augenlicht L.H., 2010. Altered dynamics of intestinal cell maturation in Apc1638N/+ mice. Cancer Research 70: 5348-5357.
41. Wu, G.Y., 1998. Intestinal mucosal amino acid catabolism. Journal of Nutrition 128: 1249-1252.
42. Zeissig, S., Kaser, A., Dougan, S.K., Nieuwenhuis, E.E. and Blumberg, R.S., 2007. Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity. American Journal of Physiology - Gastrointestinal and Liver Physiology 29: G1101-G1105.
43. Zhao, J., Kim, K.D., Yang, X., Auh, S., Fu, Y.X. and Tang H., 2008. Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proceedings of the National Academy of Sciences of the USA 105: 7528-7533.